INSIGHTS ON QUALITY CONTROL
-
Elevating Environmental Monitoring Trending: From Data To Insight
Move beyond raw data by using heat maps and site-specific limits to identify contamination hotspots. Transform your environmental monitoring into a proactive strategy for operational excellence.
-
Enhance Peptide Innovation With A High-Quality Supply Of Building Blocks
To leverage the benefits of peptide therapeutics, identify an experienced chemical material manufacturer that can produce unique peptide building blocks with quality, efficiency, and continuous compliance.
-
Practical Considerations For Aseptic Gowning In Contamination Control Strategies
Master the complexities of aseptic gowning and Annex 1 compliance. Explore risk-based strategies to mitigate human-source contamination and strengthen your facility's sterility assurance.
-
How LIMS Supports QC Scaling At Forge Biologics
Modernizing QC workflows with cloud-based systems eliminates paper inefficiencies, reduces errors, and accelerates reporting. Discover how streamlined processes improve compliance and enhance data visibility.
-
Practical Solutions For Protein Analytics And Residual DNA Testing11/12/2025
Discover practical solutions for common quality control bottlenecks in biotherapy manufacturing. Learn how to improve protein analytics and DNA testing robustness and accelerate time to market.
-
Software Simplifies 21 CFR Part 11 and Annex 11 Compliance12/9/2024
21 CFR Part 11 and Annex 11 regulate electronic records and signatures in biomanufacturing, ensuring data integrity, security, and compliance while enabling efficient processes and regulatory alignment.
-
Strategic CMC Planning Through A Phase-Appropriate Quality Approach5/28/2024
A phase-appropriate quality approach ensures quality activities align with the unique risks and challenges of each development stage. Watch to learn how to apply such an approach to chemistry, manufacturing, and controls planning.
-
Navigating The Analytical Complexity Of Oligonucleotide Therapeutics9/13/2024
From identity and purity testing using chromatography and electrophoresis to PCR and microbial studies, explore advanced analytical solutions tailored for siRNA, miRNA, pDNA, and mRNA products.
-
Effect Of X-Ray Inspection On Pharmaceutical Products7/23/2024
Explore the use of X-ray inspection systems for the internal examination of pharmaceutical products, particularly non-transparent packaged drugs.
QUALITY CONTROL SOLUTIONS
-
The Palltronic Flowstar V integrity test instrument ensures accurate filter integrity testing with a further reduction in test time, full compliance with 21 CFR Part 11, advanced automation capabilities, and simplified network integration saving the user time while improving process efficiency.
-
TSI’s cleanroom facility environmental monitoring products with built-in redundancy provide the confidence you need to reliably monitor critical processes and demonstrate compliance.
-
Batch and lot testing for release are critical steps in ensuring the quality and consistency of pharmaceutical tablets. Natoli Scientific provides comprehensive batch testing services that align with stringent industry standards and regulatory requirements. Each lot undergoes a rigorous analysis to verify that it meets predefined specifications for weight, tablet breaking force, thickness, diameter, and dissolution, among other critical quality attributes. The testing process is meticulously designed to screen for any variation that could impact the efficacy or safety of the final product.
Utilizing state-of-the-art analytical equipment and methodologies, our experts ensure that each batch released by our clients is of the highest quality, providing end-users with the assurance that the medications they rely on are both safe and effective. This level of attention to detail fosters trust and reliability in pharmaceutical products processed through Natoli Scientific’s advanced batch and lot testing services.
-
Choose the ideal mix of services with our FlexUP Technology Renewal Program for continuous operation in your laboratory and across your enterprise.